Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos)

被引:0
作者
Alexandra Papaioannou
Lawrence Joseph
George Ioannidis
Claudie Berger
Tassos Anastassiades
Jacques P. Brown
David A. Hanley
Wilma Hopman
Robert G. Josse
Susan Kirkland
Timothy M. Murray
Wojciech P. Olszynski
Laura Pickard
Jerilynn C. Prior
Kerry Siminoski
Jonathan D. Adachi
机构
[1] McMaster University,Department of Medicine, St. Joseph’s Hospital
[2] McGill University,Department of Epidemiology and Biostatistics
[3] McGill University,CaMos Analysis Centre
[4] Queen’s University,Division of Rheumatology, Department of Medicine; Department of Community Health and Epidemiology
[5] Laval University,Department of Medicine
[6] University of Calgary,Department of Medicine
[7] Queen’s University,Clinical Research Centre, Kingston General Hospital and the Department of Community Health and Epidemiology
[8] University of Toronto,Department of Medicine, St. Michael’s Hospital
[9] Dalhousie University,Department of Community Health and Epidemiology
[10] University of Saskatchewan,Department of Medicine
[11] University of British Columbia,Department of Medicine/ Endocrinology
[12] University of Alberta,Department of Radiology and Diagnostic Imaging and Division of Endocrinology and Metabolism, Department of Internal Medicine
[13] Hamilton Health Sciences Corporation,Chedoke Division, Geriatric Medicine
来源
Osteoporosis International | 2005年 / 16卷
关键词
Nonvertebral fractures; Postmenopausal women; Prospective; Risk factors; Vertebral fractures;
D O I
暂无
中图分类号
学科分类号
摘要
Utilizing data from the Canadian Multicentre Osteoporosis Study (CaMos), we examined the association between potential risk factors and incident vertebral and nonvertebral fractures. A total of 5,143 postmenopausal women were enrolled. Information collected during the study included data from the CaMos baseline and annually mailed fracture questionnaires, the Short Form 36 (SF-36), the Health Utilities Index, and physical measurements. Participants were followed for 3 years. Postmenopausal women were classified into four groups according to their incident fracture status since baseline: those without a new fracture; those with a new clinically recognized vertebral fracture; those with an incident nonvertebral fracture at the wrist, hip, humerus, pelvis, or ribs (main nonvertebral fracture group); and those with any new nonvertebral fracture (any-nonvertebral-fracture group). We performed multivariate Cox proportional hazard analysis using all possible risk factors to determine the association between risk factors and the time to the first minimal trauma fracture. Best predictive models were also determined using variables that were included in the full models. The Bayesian information criterion was used for model selection. For all analyses, relative risks and associated 95% confidence intervals were calculated. During the follow-up period, 34, 163, and 280 women developed a vertebral, a main nonvertebral, or any nonvertebral fracture, respectively. The best predictive models indicated that a five point lower quality of life as measured by the SF-36 physical component summary score was associated with relative risks of 1.21 (95% CI, 1.02 to 1.44), 1.17 (95% CI, 1.07 to 1.28), and 1.19 (95% CI, 1.11 to 1.27) for incident vertebral, main nonvertebral, and all nonvertebral fractures, respectively. In addition, for a one standard deviation (SD=0.12) lower femoral neck BMD, the relative risks for incident vertebral, main nonvertebral, and any nonvertebral fractures increased by 2.73 (95% CI, 1.74 to 4.28), 1.39 (95% CI, 1.06 to 1.82), and 1.34 (95% CI, 1.09 to 1.65), respectively. Furthermore, various anthropometric measures, disease conditions, and medications are associated with a new fracture. Identifying postmenopausal women at risk is important given that fracture prevention therapies are now available.
引用
收藏
页码:568 / 578
页数:10
相关论文
共 57 条
  • [1] Kannue LJ(1993)Evidence-based assessment of pharmaceutical interventions Lancet 353 802-S20
  • [2] Lips undefined(1997)undefined Am J Med 103 3S-undefined
  • [3] Melton undefined(1992)undefined J Bone Miner Res 7 1005-undefined
  • [4] Bengner undefined(1986)undefined Acta Orthop Scand 57 2297-undefined
  • [5] Luthje undefined(1995)undefined Acta Orthop Scand 66 245-undefined
  • [6] Kanis undefined(2001)undefined Osteoporos Int 12 417-undefined
  • [7] Nguyen undefined(2001)undefined Am J Epidemiol 153 587-undefined
  • [8] Melton undefined(1998)undefined Osteoporos Int 8 S17-undefined
  • [9] Brown undefined(2002)undefined CMAJ 167 S1-undefined
  • [10] Cummings undefined(1995)undefined N Engl J Med 332 767-undefined